GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jamjoom Pharmaceuticals Factory Co (SAU:4015) » Definitions » Price-to-Owner-Earnings

Jamjoom Pharmaceuticals Factory Co (SAU:4015) Price-to-Owner-Earnings : (As of May. 29, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Jamjoom Pharmaceuticals Factory Co Price-to-Owner-Earnings?

As of today (2025-05-29), Jamjoom Pharmaceuticals Factory Co's share price is ﷼172.00. Jamjoom Pharmaceuticals Factory Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings or its related term are showing as below:


SAU:4015's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.98
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-29), Jamjoom Pharmaceuticals Factory Co's share price is ﷼172.00. Jamjoom Pharmaceuticals Factory Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ﷼5.86. Therefore, Jamjoom Pharmaceuticals Factory Co's PE Ratio (TTM) for today is 29.35.

As of today (2025-05-29), Jamjoom Pharmaceuticals Factory Co's share price is ﷼172.00. Jamjoom Pharmaceuticals Factory Co's EPS without NRI for the trailing twelve months (TTM) ended in was ﷼6.17. Therefore, Jamjoom Pharmaceuticals Factory Co's PE Ratio without NRI for today is 27.90.

During the past 5 years, Jamjoom Pharmaceuticals Factory Co's highest PE Ratio without NRI was 41.71. The lowest was 24.17. And the median was 30.26.


Jamjoom Pharmaceuticals Factory Co Price-to-Owner-Earnings Historical Data

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jamjoom Pharmaceuticals Factory Co Price-to-Owner-Earnings Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
- - - - -

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings falls into.


;
;

Jamjoom Pharmaceuticals Factory Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=172.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jamjoom Pharmaceuticals Factory Co  (SAU:4015) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Jamjoom Pharmaceuticals Factory Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Jamjoom Pharmaceuticals Factory Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Jamjoom Pharmaceuticals Factory Co Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box No. 6267, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.

Jamjoom Pharmaceuticals Factory Co Headlines

No Headlines